BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 17892862)

  • 1. Mitotic regulation of CDK4 by the serine/threonine phosphatase, calcineurin.
    Chow R; Olesen J; Onyskiw C; Baksh S
    Biochem Biophys Res Commun; 2007 Nov; 363(3):506-12. PubMed ID: 17892862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Serrano M; Hannon GJ; Beach D
    Nature; 1993 Dec; 366(6456):704-7. PubMed ID: 8259215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
    Wang J; Walsh K
    Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal domain of p16(INK4a) is adequate in inducing cell cycle arrest, growth inhibition and CDK4/6 interaction similar to the full length protein in HT-1080 fibrosarcoma cells.
    Fahham N; Sardari S; Ostad SN; Vaziri B; Ghahremani MH
    J Cell Biochem; 2010 Dec; 111(6):1598-606. PubMed ID: 21053367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R; Laín S; Ball KL; Lane DP
    Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.
    Russo AA; Tong L; Lee JO; Jeffrey PD; Pavletich NP
    Nature; 1998 Sep; 395(6699):237-43. PubMed ID: 9751050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.
    Suzuki A; Hayashida M; Ito T; Kawano H; Nakano T; Miura M; Akahane K; Shiraki K
    Oncogene; 2000 Jul; 19(29):3225-34. PubMed ID: 10918579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
    Al-Khalaf HH; Hendrayani SF; Aboussekhra A
    Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells.
    Sandhu C; Peehl DM; Slingerland J
    Cancer Res; 2000 May; 60(10):2616-22. PubMed ID: 10825132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.
    Haas K; Staller P; Geisen C; Bartek J; Eilers M; Möröy T
    Oncogene; 1997 Jul; 15(2):179-92. PubMed ID: 9244353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
    Easton J; Wei T; Lahti JM; Kidd VJ
    Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
    Ando K; Griffin JD
    Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity.
    Li J; Li H; Tsai MD
    Biochemistry; 2003 Jun; 42(22):6921-8. PubMed ID: 12779347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
    Calbó J; Serna C; Garriga J; Graña X; Mazo A
    Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.